Showing results (171-180 of 1,011) with videos related to
Sort By:
Pageof 102
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 26, 2002
[Biological markers for acute phase hemostasis in coronary thrombosis]I Elalamy, G Gerotziafas, R Dumaine, et al.Annales Francaises D'Anesthesie Et De Reanimation|July 26, 2005
[Prevention of venous thromboembolism in surgery and obstetrics]C-M Samama, P Albaladejo, S Laversin, et al.The Annals of Thoracic Surgery|December 1, 1996
Reduction in requirements for allogeneic blood products: nonpharmacologic methodsJ F Hardy, S Bélisle, G Janvier, et al.Annales De Medecine Interne|January 1, 1986
[Thrombolytic treatment in the acute phase of myocardial infarction. Evaluation in 1986]A Kher, P L Michel, M Samama, et al.Journal Des Maladies Vasculaires|June 25, 2013
[Hemorrhagic accidents of the new oral anticoagulants and coagulation assays]M M Samama, J Conard, A Lillo-Le LouëtChest|June 20, 2000
A European view on the North American fifth consensus on antithrombotic therapyM Verstraete, C R Prentice, M Samama, et al.Journal Des Maladies Vasculaires|June 3, 1998
[Staphylokinase and its mutants: a new generation of thrombolytic agents]J Lebrazi, I Elalamy, G Helft, et al.Annales De Biologie Clinique|January 1, 1983
[Demonstration of spontaneous platelet aggregation and research on circulating platelet aggregates: methodology, results and significance]C Lecrubier, J Conard, M H Horellou, et al.Pathologie-Biologie|September 24, 2005
[Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases]S Guermazi, J Conard, M M Samama, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|March 1, 1990
[Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients]I Gouin, M H Horellou, J Conard, et al.Pageof 102